Many health and wellness stocks have faced challenges in recent years as GLP-1 weight-loss drugs like Ozempic and Wegovy upend the traditional diet market. Companies that once dominated the space have ...

In the Age of Ozempic, ... Just two months after filing for bankruptcy, ... but her move to WeightWatchers—a legacy weight-loss empire that has been around since 1961—is a step in a ...

WeightWatchers said its forthcoming menopause programme — which will deliver “tailored nutritional and behavioural strategies” — is a “strategic move to address a broader gap in healthcare”.